Testing the Persuasiveness of Pro-inoculation Arguments
Message Testing Protocol for Misinformation Concerns
1 other identifier
interventional
523
1 country
1
Brief Summary
The investigators will recruit a national sample of parents of 7-10-year-olds to complete an argument strength ranking for either a simple forwarding message or between 3 and 6 randomly selected arguments from an overall set of 50 to 100 messages identified from various online sources. Parents will rate each message they see on measures of perceived argument strength/PME. Parents will also answer sociodemographic questions and then rank the believability of a set of anti-vaccine messages identified in a different study. Study findings will contribute valuable information to understanding the effectiveness of different inoculation messages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2022
CompletedFirst Posted
Study publicly available on registry
April 7, 2023
CompletedStudy Start
First participant enrolled
May 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2023
CompletedJuly 11, 2023
July 1, 2023
20 days
October 20, 2022
July 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Argument strength/PME
Arguments will be rated for their argument strength/message effectiveness
The outcome measure will be assessed immediately after the participant has viewed each pro-HPV vaccine message if they are in the multiple message condition, or the simple message if they are in the simple message condition stimuli during the survey.
Misinformation believability
A rating of the believability/ credibility of vaccine misinformation
The outcome measure will be assessed immediately after the participant has viewed each misinformation message during the survey.
Study Arms (2)
Simple forewarning message
ACTIVE COMPARATORParticipants will receive a simple short forewarning message to read and rate.
Argument inoculation messages
EXPERIMENTALParticipants will view a random sample of 3 text-only short messages (from a corpus of 100 arguments) to read and rate.
Interventions
Participants will then be presented with arguments randomly selected by the Qualtrics software algorithm from the full set of messages.
Participants will be presented with a simple forewarning message.
Eligibility Criteria
You may qualify if:
- Male or female parent or legal guardian of an adolescent ages 7-10
- Age eligible child has not yet received any doses of the HPV vaccine
- Resides in the United States
- English speaking
- Completed informed consent
You may not qualify if:
- Unable to read English at a 6th grade literacy level
- Age \< 18
- Does not have a child within the age range of 7-10
- Age-eligible child has received 1 or more doses of the HPV vaccine
- Unwilling or unable to provide informed consent to study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPenn
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2022
First Posted
April 7, 2023
Study Start
May 4, 2023
Primary Completion
May 24, 2023
Study Completion
May 24, 2023
Last Updated
July 11, 2023
Record last verified: 2023-07